QCM
RDY icon

Quantinno Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Quantinno Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.82M Buy
637,094
+264,856
+71% +$3.69M 0.01% 923
2025
Q4 		$5.23M Buy
372,238
+53,588
+17% +$752K 0.01% 1022
2025
Q3 		$4.45M Buy
318,650
+83,606
+36% +$1.2M 0.01% 953
2025
Q2 		$3.53M Buy
235,044
+112,988
+93% +$1.61M 0.02% 934
2025
Q1 		$1.61M Buy
122,056
+14,867
+14% +$205K 0.01% 1029
2024
Q4 		$1.69M Buy
107,189
+6,004
+6% +$90.2K 0.02% 904
2024
Q3 		$1.61M Buy
101,185
+15,470
+18% +$249K 0.02% 808
2024
Q2 		$1.31M Buy
85,715
+24,430
+40% +$350K 0.02% 719
2024
Q1 		$899K Buy
61,285
+15,175
+33% +$222K 0.02% 769
2023
Q4 		$642K Buy
46,110
+11,185
+32% +$150K 0.02% 751
2023
Q3 		$467K Buy
34,925
+4,565
+15% +$61.8K 0.02% 743
2023
Q2 		$383K Buy
30,360
+4,800
+19% +$56K 0.02% 696
2023
Q1 		$291K Sell
25,560
-21,585
-46% -$233K 0.02% 725
2022
Q4 		$488K Buy
+47,145
New +$509K 0.04% 549

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Quantinno Capital Management's RDY Position: Q1 2026 in Review

Quantinno Capital Management increased its Dr. Reddy's Laboratories (RDY) stake by 71% in Q1 2026, buying an estimated $3.69M and bringing the position to 637,094 shares worth $8.82M. The position accounts for 0.01% of the portfolio, ranked #923.

Quantinno Capital Management first reported a position in RDY in Q4 2022 and has held it in 14 quarters since. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Quantinno Capital Management held 637,094 shares of Dr. Reddy's Laboratories worth $8.82M as of Q1 2026.
  • Quantinno Capital Management bought 264,856 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $3.69M.
  • Dr. Reddy's Laboratories made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #923 holding.
  • Quantinno Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 14 quarters since.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.